[1] 马世武, 刘成海, 刘晓琰, 等. 中国药物性肝损伤诊治指南(2023年版). 胃肠病学, 2022, 27(06): 341-375. [2] Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med, 2001, 344(7): 495-500. [3] Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med, 2017, 377(8): 756-768. [4] 于乐成, 茅益民, 陈成伟. 药物性肝损伤诊治指南. 实用肝脏病杂志, 2017, 20(02): 257-274. [5] Wang Q, Huang A, Wang JB, et al. Chronic drug-induced liver injury: updates and future challenges. Front Pharmacol, 2021, 12: 627133. [6] Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology, 1988, 95(3): 734-739. [7] Eminler AT, Ayyildiz T, Irak K, et al. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur J Gastroenterol Hepatol, 2015, 27(12): 1361-1366. [8] Fallatah HI, Akbar HO, Fallatah AM. Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for assessment of liver fibrosis in saudi patients with nonalcoholic fatty liver disease. Hepat Mon, 2016, 16(7): e38346. [9] Sheth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol, 1998, 93(1): 44-48. [10] Oeda S, Tanaka K, Oshima A, et al. Diagnostic accuracy of FibroScan and factors affecting measurements. Diagnostics (Basel), 2020, 10(11). [11] 瞬时弹性成像技术(TE)临床应用专家共识(2015年). 中国肝脏病杂志(电子版), 2015, 7(02): 12-18. [12] Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38(2): 518-526. [13] Houot M, Ngo Y, Munteanu M, et al. Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Aliment Pharmacol Ther, 2016, 43(1): 16-29. [14] Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology, 2015, 61(1): 292-302. [15] Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology, 2017, 66(5): 1486-1501. |